key: cord-0741422-itj5c3a9 authors: van Wezel, Ralph A.C.; Vrancken, Anne C.T.; Ernest, Marieke; Laurensse, Johan; van Doornmalen Gomez Hoyos, Josephus P.C.M. title: In hospital verification of non CE-marked respiratory protective devices to ensure safety of healthcare staff during the COVID-19 outbreak date: 2020-05-20 journal: J Hosp Infect DOI: 10.1016/j.jhin.2020.05.023 sha: 8eba7cc5e05b4fee8352ead322ff5d5bd8d2dc76 doc_id: 741422 cord_uid: itj5c3a9 AIM: To develop a protocol to ensure the quality of respiratory protective devices for healthcare workers nursing and treating patients with possible or confirmed COVID-19 in the Catharina hospital. BACKGROUND: Due to the COVID-19 outbreak a shortage of respirators is occurring worldwide; more specifically, CE-certified FFP2 respirators. This has resulted in an increased supply to hospitals of alternative respirators of uncertain quality. Nevertheless, the quality of the respirators used by our healthcare workers must be ensured. METHOD: A protocol and criteria based on applicable standards was developed to ensure the quality of respirators. The protocol has been implemented at the Catharina hospital and includes verification of the documents accompanying the respirator, visual inspection of the respirator and a test for total inward leak of particles into respirators. FINDINGS: 67% of the respirators brands and types received in the Catharina hospital did not meet quality criteria. CONCLUSION: With a simple verification protocol the quality of the respirators can be checked and guaranteed while there is a shortage of the CE approved respirators which are normally used. With this in-hospital protocol health care workers can be equipped with safe-to-use respirators. Aim: To develop a protocol to ensure the quality of respiratory protective devices for healthcare workers nursing and treating patients with possible or confirmed COVID-19 in the Catharina hospital. Background: Due to the COVID-19 outbreak a shortage of respirators is occurring worldwide; more specifically, CE-certified FFP2 respirators. This has resulted in an increased supply to hospitals of alternative respirators of uncertain quality. Nevertheless, the quality of the respirators used by our healthcare workers must be ensured. Method: A protocol and criteria based on applicable standards was developed to ensure the quality of respirators. The protocol has been implemented at the Catharina hospital and includes verification of the documents accompanying the respirator, visual inspection of the respirator and a test for total inward leak of particles into respirators. Findings: 67% of the respirators brands and types received in the Catharina hospital did not meet quality criteria. Healthcare workers caring for patients with possible or confirmed COVID-19 have to be protected against contamination. In Europe, in normal circumstances, the `respiratory protective devices' (in short, respirators) used by these healthcare workers have to comply with the standard EN149+A1:2009 [1] . Most respirators used in hospitals are single-use. As a result of theCOVID-19 outbreak, an exceptionally large demand for these respirators has arisen and shortages has occurred. Authorities have published recommendations to overcome shortages of these respirators [2, 3] . In Europe, national authorities have indicated that during the COVID-19 crisis the restriction of solely using CE certified respirators no longer applies [4] . As a consequence, the European market is flooded with respirators of unknown or uncertain quality [5] . Nevertheless, it is imperative that the safety of the healthcare workers is ensured. Therefore, the Catharina hospital developed a protocol that would allow local (in-hospital) verification of the quality of these respirators before clearance for use by staff. The protocol was developed through an interdisciplinary project team comprising a pharmacist, bio-medical engineer, infection preventionist, project manager and a physicist. The protocol includes verification of the documentation accompanying the respirator, a visual inspection of the respirator and finally the testing of full filter efficiency of the respirator. The filter efficiency is compared with the values of a premium CE-marked respirator that complies with EN149+A1:2009 [1] . The standard EN149+A1:2009 [1] specifies three categories, FFP1, FFP2 and FFP3, where FFP stands for `Filtering Face-Piece'. FFP1-, FFP2-and FFP3-certified respirators must meet a `Total Inward Leak' (TIL) of 22 %, 8% and 2% respectively. These percentages indicate the maximum number of particles that may `leak' through the respirator during testing. The test should reflect the practical use of the respirator. The Dutch `National Institute for Public Health and the Environment' (RIVM) recommends the use of the FFP2 type when nursing and treating COVID-19 infected patients, during aerosol generating procedures [6] . Apart from the FFP2 respirator there are two other types of certified respirators on the worldwide market that have comparable properties. These are the `N95'-and `KN'95'-qualified respirators. Both types of respirators have been introduced in Dutch hospitals due to the shortage of FFP2 respirators. The N95 variant is commonly used in the US and meets the requirements of the NIOSH-42CFR8 [7] . The U.S. Food & Drug Administration (FDA) specifies: `The `N95' designation means that when subjected to careful testing, the respirator blocks at least 95 percent of very small (0.3 micron) test particles' [8] . The other variant is the `KN95' respirator meeting the Chinese requirements [9] . This respirator has a similar requirement for particle blocking as the N95 qualified respirators. In normal circumstances the production facility/company has responsibility for the claims and quality of the respirators. The quality system of the production facility and quality of the final product is approved by a European certified notified body. However, currently, the origin of the respirators that are supplied to the hospitals is not always traceable. In this paper a protocol is specified for a quick and robust method to locally (in hospital) verify the quality of non CE marked respirators to ensure safety of the staff in the Catharina hospital during the COVID-19 pandemic. During the COVID-19 crisis, the process of document verification and first test of alternative respirators upon at arrival in the hospital comprises the following steps: • verification of the documents accompanying the respirator: o verification if the documents belong to the delivered product o verification of the certificates of the product o verification of the Instruction for Use (IfU) visual inspection: • visually check the quality and marking on the respirator (e.g., conformity mark, notified body number, classification, expiration date). • correct method of packaging (e.g., packaging is dust-proof and correctly sealed) • information on the packaging (e.g., manufacturer, type and duration of use) • face fitting of the respirator on at least 5 people. • ensure that the nose piece closes properly. • visual inspection and/or soft blowing through the nose to identify potential leakage on the side and seals (if unexpected leaks are observed the respirator is rejected). • test for water repellence by dropping a few drops of water on the outside of the respirator (droplets should roll off and should not be absorbed and penetrate the respirator). • test the sealing welds by illuminating with a lamp and carefully pulling the seal apart (If the welds are transparent and the seal simply tears, the respirator is rejected). o respirators consisting of three layers: outside moisture-proof, inside polypropylene fibres (coarse-mesh and feels firm), inside comfort layer, and, o respirators consisting of three or more layers as above, but the middle layer consists of one or more layers of fine-meshed organic material (high-quality respirators have an inner-layer consisting of three layers, so that the respirator comprises at least 5 layers). If the expected layers are not recognised or present, the respirator is rejected. If the documentation verification and the visual inspection meet the requirements, the respirator is subjected to a TIL test to evaluate the full filter efficiency in a test-rig. `Full filter' means that the area of the respirator that functions as a filter is subject to the test, rather than a part or parts of the filter area. In the cases in which particle tests have to be performed, ten respirators are randomly taken from the received batch. If the first five do not meet the criteria for the full filter test the respirators are rejected for use in the hospital (Figure 3 ). If the first five respirators meet the criteria, another five are tested using the same test procedure. If the second five also meet the criteria, the respirator batch can be released for use. Therefore, before releasing a batch of respirators for use in the hospital, ten respirators are tested. The lay-out of the test-rig is shown in Figures 1 and 2 . The test-rig is laid out to facilitate testing of the full or complete filter of the respirator (figure 2b), with a channel diameter of 0.16 m. The total length of the test channel is approximately 2.30 m, with 1.30m between the respirator and the open end of the channel, a Perspex mould to house the respirator, and a `clean' area of approximately 1m between the respirator and the closed end of the channel. For each respirator brand and type, a dedicated mould is constructed (e.g., Figure 2c ). The moulds were constructed by the technical department of the hospital. Figure 2d displays the particle counters (type 3016, Lighthouse worldwide solutions, Fremont, CA, USA). One particle counter measures the `dirty' area before the filter, the other measures the clean area after the filter, (figure 1). The unexpected and immediate situation of shortage of masks forced the hospital and project team to build a test rig with equipment that was available at short notice. To ensure that the measurements were valid, a premium and CE certified mask was used as reference. The results of the measurements with this mask demonstrated that the method of measuring was compliant with the EN149+A1: With the low flow velocity and a stabilisation time of one minute before particle measurements are started, the flow in the channel is assumed to be a laminar flow. The velocity of the air flow, measured in the axial centre are in the order 0.5 m/s depending on the load in the channel. The average velocity can then be calculated with ̅ = [10] , and is in the order of 0.25 m/s. This is in the orders of the flows as specified in the standard EN149+A1:2009 [1] . In the absence of a particle generator or salt spraying equipment in the hospital, the background load of particles in the test environment was used as load for the filter test. This particle distribution is likely to be similar to that found in a ward of the Catharina hospital and is therefore a suitable particle load for the test. After stabilisation of the flow, five sequential samples are taken simultaneously with both particle counters, each with a sample time of one minute. In each sample the particles are counted by the particle counters. The measurements are performed using a hand-held Lighthouse 3016 particle counter (Fremont CA, USA, figure 2d ). This device distinguishes between particles sized 0.3, 0.5 1.0, 3.0 5.0 and 10.0 µm. In a measurement session, five of the same brand and type of respirators are measured ( figure 3 ). This delivers a total of 25 measurements per brand-type of respirator per session. All tests with the test-rig are performed with an environmental temperature of 23 ± 2 °C and a relative humidity of 36 ± 5 %. These values are within the specifications of the standard [1] . In the flowchart for data acquisition on particles (figure 3) it is specified that the measurement or data-acquisition sessions have to start and end with a zero measurement. In these measurements no respirator is positioned in the test-rig (figures 1 and 2) . Data handling Because the channel does not leak, the gas composition at the sampling point `dirty' and `clean' are similar. Although two identical and calibrated particle measurement devices are used, a (small) difference in measurement between these devices may occur. To eliminate this systematic difference between the two devices a correction factor per particle size is applied: Using the CFs, the percentage of particles passing the respirator is calculated by: Particles going through the filter 4%6 = 7 !#$ #$ ! × 9: Furthermore, the CFs are used to judge the change (di_erence) of particles at the start and at the end of a measurement session. The di_erences in CFs have to be checked manually because the measured number of particles (not presented here) can lead to an incorrect interpretation. An example of a processed dataset is presented in table 1. To set a reference for accepting or rejecting a respirator, a CE-marked A-brand FFP2 respirator was selected. Ten respirators were tested according to the test protocol ( figure 3 ). This set was marked as the `reference'. Results of all tested respirators were compared to this reference and to the FFP2 criteria. Additionally, a threshold of 8% particles passing the filter is the used for accepting and rejecting a respirator as in the TIL test in the standard EN149+A1:2009 [1] . The results of document verification, visual inspection and measurements of the respirators are evaluated by the specified departments. Only when the final decision on a respirator is positive is the batch of respirators accepted and released for use in the hospital. At the time of writing our verification protocol had been applied to 22 batches of respirators, including the reference mask. Ultimately, 7 out of the 21 (33 %) batches met the requirements of the Catharina hospital, and were released for use. In 8 (38 %) cases the documentation or visual inspection did not meet our criteria; these respirators were immediately rejected and returned to the supplier. Therefore, the full filter test with the test-rig has been performed on thirteen respirator batches according the flowchart in figure 3 . Figure 4 shows the results of the thirteen respirators tested for filter efficiency. For the reference data set (indicated with `ref'), the maximum average percentage of particles passing the respirator was 4.99% (range: 3.26 % -6.88%) for 0.3 µm particles, which is well below the maximum TIL of 8% for FFP2 respirators, as specified by the EN149+A1:2009. The figure 4 shows that 7 out of 13 (54 %) of the respirators have met the criteria of the Catharina Hospital for the full filter test with the test-rig. The brands and types are not disclosed because it does not add value in the development of the test protocol for respirators. The results of our test protocol were that only 33% of the tested respirators met the requirements of the hospital. This result stresses the importance of testing received respirators to ensure the safety of our healthcare workers at this moment in time. Therefore, the protocol has been implemented in the hospital. The protocol will remain in place as long as a shortage of respirators persists. Although the full filter test in the test-rig is in line with the specification in the standard [1] it differs in some respects. For example, the flow through the respirator is a constant flow, and while, in the standard, breathing is mimicked, the flow applied in the test-rig is higher than the flow of a human being. The constant and higher flow is more challenging than the `human breathing' flow. The environmental conditions during the tests meet the requirements in the standard. However the breath of a human is specified in the standard on 37 _ 2 _C and the RH at 95 %. It can be argued that a moist respirator is more difficult for particles and air to penetrate than a dry respirator. It is therefore assumed that the tests in the test-rig are more challenging for the respirator. To ensure that no pathogens can come through the filter material via the moisture, the IfU of masks specify the duration of use. This duration of use may vary per masks. The Dutch authorities recommend a duration of three hours. In the Catharina hospital this duration of use is limited to two hours to increase safety [12] . The number of ten samples for full filter test in the test-rig is limited. However, the EN149+A1:2009 [1] prescribes a sample size of 10 pieces for the Total Inward Test. This sample size is related to the production batches of 100,000 or more. Therefore, a sample sizes of 10 is justified for in-hospital testing with batches smaller than 100,000 masks. In conclusion, a robust and easy-to-perform protocol was developed for the in-hospital quality verification of respiratory protective devices. By applying this protocol to all batches of respirators delivered to the Catharina Hospital, safety is assured for the healthcare staff during the COVID-19 crisis. 2c ). The particles coming with the flow into the channel are measured at two locations with two separate particle counters (Lighthouse Hand-held 3016, Fremont CA, USA, figure 2d), one before and one after the location of the respirator. Additional to the iso-kinetic measurements system of the particle counters, the sampling for particle counting is performed via a horizontally placed Pitot tube. This ensures that the sampling is in the axial opposite direction of the air flow. The black dots between the mould and channel represent a seal to exclude air-leaks into the channel. To exclude the possibility of accumulating static electric charge in the channel wall, the metal channel is grounded to earth. All equipment used in the test-rig was available in the technical department of the hospital. , 22 %, 8% and 2% respectively. Because the reference stays within the limit of the FFP2 respirator, this limit is used as the acceptance criteria for the full filter test. Based on these results the respirators D, E, G, F, H, J and L meet the criteria. The brands and types are not disclosed because it does not add value in the development of the test protocol for respirators. European Committee for Standardization: Respiratory protective devices -Filtering half masks to protect against particles -Requirements, testing, marking Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic, Board on Health Sciences Policy. Reusability of Facemasks during an influenze pandemic Dutch National Institute for Public Health and the Environment (RIVM) National Institute for Occupational Safety and Health (NIOSH) personalprotective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks Standardization Administration of the People's Republic of China: Respiratory protective devices -Filtering half masks to protect against particles -Requirements, testing, marking Transport Phenomena 2nd edition standard ISO 14644-1. Cleanrooms and associated controlled environments | Part 1: Classi_cation of air cleanliness by particle concentration Dutch National Institute for Public Health and the Environment (RIVM) At the right end, the hose to the vacuum pump. (b) Front view of test-rig with a respirator loaded in channel for testing. (c) Example of a respirator in a dedicated mould Figure 2: Test-rig set-up for respirator testing The authors wish to thank Alexander Fransen, Fleur Jacobs, Tomas Kaandorp and Bas van Mil for their constructive and practical contributions during setting up and performing the document verification, visual inspections, the test-rig and measurements.